CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Clinical trials for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC RHINOSINUSITIS WITH NASAL POLYPS trials appear
Sign up with your email to follow new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug offers hope for chronic nasal polyp sufferers in china
Disease control Not yet recruitingThis study tests a drug called tezepelumab in 230 Chinese adults with chronic sinusitis and nasal polyps. The goal is to see if it reduces polyp size and improves nasal congestion over 24 weeks. Participants receive the drug as an injection, and doctors measure changes using nasa…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New drug could shrink nasal polyps and ease breathing
Disease control Not yet recruitingThis study tests a new drug called itepekimab in Japanese adults with chronic sinusitis and nasal polyps that are not well controlled by standard treatments. The goal is to see if the drug can shrink polyps and improve nasal congestion over 52 weeks. About 20 participants will re…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for stuffy noses: drug targets nasal polyps
Symptom relief Not yet recruitingThis study tests an experimental drug called CM326 in 212 adults with chronic sinusitis and nasal polyps (growths in the nose). The goal is to see if it shrinks polyps and eases congestion better than a placebo. Participants will receive the drug or placebo for 24 weeks, followed…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 05:12 UTC